Busque Philippe bought CTKB

March 20, 2024 · Form 4 insider transaction

Busque Philippe bought 5,464 shares of Cytek Biosciences, Inc., a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.

Direction

Acquired (buy-side)

5,464

Price

N/A

Total value

N/A

InsiderBusque Philippe

RoleOfficer

CompanyCytek Biosciences, Inc. (CTKB)

SecurityCommon Stock

Transaction codeM — Option exercise

Transaction dateMarch 20, 2024

Filing dateMarch 21, 2024

Shares owned after5,464

OwnershipDirect

10b5-1 planNo

AmendedNo

Footnotes

Each Restricted Stock Unit (the "RSU Award") represents a contingent right to receive one share of the Issuer's common stock.

View the original Form 4 on SEC EDGAR